Takeda snaps up Amgen products
February 6, 2008Sales and Marketing
Takeda has bought marketing rights to 13 of Amgen's early stage products, boosting its flagging pipeline and letting Amgen recoup …
Government and industry agree on collaboration guidelines
February 1, 2008New guidelines to help NHS bodies work with the pharmaceutical industry have been agreed after months of negotiation, and could …
New consortium to run NHS clinical audit programme
February 1, 2008The Department of Health has reorganised the way audits of patient care are carried out, handing the running of its …
Torisel poised to gain lymphoma licence
February 1, 2008Sales and Marketing
Wyeth's new cancer drug Torisel is set to gain approval for use in patients with a rare and difficult to …
Tamiflu resistance hits Roche
February 1, 2008Sales and Marketing
Sales of the blockbuster flu treatment Tamiflu could receive a setback from new data showing significant resistance to the drug. …
AstraZeneca sales strong despite Nexium’s decline
February 1, 2008Sales and Marketing
AstraZeneca achieved sales growth of 12% in 2007, despite a worrying decline in sales from its biggest seller, anti-ulcer drug …
Avastin’s new licence ‘more cost-effective’
January 30, 2008Sales and Marketing
Avastin has won a broader European licence for metastatic colorectal cancer, a move manufacturer Roche believes will make it more …
PM Society Awards
January 28, 2008Medical Communications advertising, awards
The Pharmaceutical Marketing Society’s Advertising Awards added their customary sparkle to the grey month of January, and celebrated the best …
‘Alsace Biovalley’ brand launched to promote region’s biotech innovation
January 28, 2008Research and Development Alsace, France, biotech
France has re-branded its leading biotech cluster the ‘Alsace Biovalley’ to help the region compete for investment in Europe and …
Novartis’ European chief says ‘Geotailoring’ will speed decision making and bring it closer to customers
January 28, 2008Sales and Marketing Eric Cornut, Novartis
Q: Europe’s biggest market Germany is preparing for some major reforms at the moment. How is Novartis responding to that …
Jimenez aims for savings and marketing rejuvenation
January 28, 2008Sales and Marketing Jimenez, Jiminez, Novartis
The head of Novartis’ pharmaceutical business Joe Jimenez has set out his plans to make the division more efficient and …
Pfizer sales dip during year of restructuring
January 25, 2008Sales and Marketing generics
Pfizer’s pharmaceutical sales fell slightly last year, hit by patent expiries and difficult market conditions for its leading drug Lipitor. …
Avandia hit by further restrictions
January 25, 2008Sales and Marketing reg, safety
GlaxoSmithKline has strengthened the safety warnings on its diabetes drug Avandia following recommendations from European regulators. The drug was hit …
Avastin launched in UK for kidney cancer
January 25, 2008Sales and Marketing avastin, rcc
Avastin has been launched in the UK as a first-line treatment for renal cell carcinoma (RCC) to be used in …
PR firm Chamberlain opens European office
January 25, 2008Medical Communications PR
American PR firm Chamberlain is to expand into Europe with the opening of new operations in London. Chamberlain Healthcare Public …
Athena picks up account for key Bayer Schering product
January 24, 2008Medical Communications
Bayer Schering Pharma has appointed Athena Medical PR to handle the UK PR campaign for its anti-coagulant Xarelto ahead of …
NICE contributes to government’s anti-obesity vision
January 24, 2008Sales and Marketing hc
The rise of obesity in Britain could be halted if exercise were built into individual daily routines, according to new …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
